Clinical Trials in Boston

Showing 5281-5300 of 17,836 trials

Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

NCT05191706

A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCUfor the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

Cataract

EyePoint Pharmaceuticals, Inc.60 participantsStarted Jan 2022

Huntington Beach, California, United States • Palo Alto, California, United States • Boston, Massachusetts, United States +6 more locations

Active Not RecruitingPhase 3< 1 mile

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

NCT05701774

The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.

Prader-Willi Syndrome

Soleno Therapeutics, Inc.83 participantsStarted Jan 2023

Orange, California, United States • Palo Alto, California, United States • San Diego, California, United States +19 more locations

Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

Find Trials by Condition in Boston

The DETOUR 2 Clinical Trial

Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)

Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations

Pilot Neurobehavioral Therapy for Functional Neurological Disorder

Low Nicotine Content Cigarettes in Vulnerable Populations: Affective Disorders

Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen

Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.

Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain

To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6)

MOTIV BTK Randomized Controlled Trial

A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)